Johanna Strotmann

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis

Epithelial Mesenchymal Transition

Cell Proliferation

Transforming Growth Factor

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner, Matthias Glanemann, Fay Betsou, Wim Ammerlaan, Ronny Schmidt, Christoph Schröder, Waldemar Uhl, Chris Braumann, Philipp Höhn
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers 16 (15) (2024)
Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner, Matthias Glanemann, Fay Betsou, Wim Ammerlaan, Ronny Schmidt, Christoph Schröder, Waldemar Uhl, Chris Braumann, Philipp Höhn
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers 16 (15) (2024)
Claudia Baron, Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Daniel Fein, Thomas Müller, Waldemar Uhl, Philipp Höhn, Johanna Strotmann, Chris Braumann
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study. International journal of molecular sciences 23 (13) (2022)